Washington HB 2304: Concerning improving diversity in clinical trials.

Status: First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (as of 2018-01-08)

State: Washington · Session: 2017-2018 · Bill: HB 2304

Subjects: DRUGS, HEALTH CARE, INSTITUTIONAL REVIEW BOARD, WASHINGTON STATE, MINORITIES, WOMEN

Sponsors: Lovick, Appleton, Doglio, Frame, Gregerson, Jinkins, Macri, McBride, Ryu, Senn, Stanford, Tarleton, Valdez

View Washington HB 2304 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.